Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China

Reuters

06-05

<a href="https://laohu8.com/S/BPMUF">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China

Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2541488540"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541488540\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2541488540?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 13:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541488540","market":"us","top_or_hot":-1,"title":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BPMUF\">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBasilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-05 13:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BPMUF\">Basilea Pharmaceutica AG</a> and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NDAQ","symbol_name":"纳斯达克OMX交易所","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL9MB7Ds:1","article_id":"2541488540","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541488540","pubTimestamp":1749100522,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China. Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe , China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba . The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide a","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"NDAQ":"纳斯达克OMX交易所","PFE":"辉瑞"},"translate_title":"Basilea Pharmaceutica AG和辉瑞加强合作伙伴关系，为Cresemba在亚太地区和中国的销售支付里程碑付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"PFE":0.9},"content_text":"Basilea Pharmaceutica AG and Pfizer Strengthen Partnership with Milestone Payment for Cresemba Sales in Asia-Pacific and China\n    \n\n        Basilea Pharmaceutica AG has announced a significant milestone in its partnership with Pfizer Inc. The collaboration, which covers Europe (excluding the Nordic countries), China, and 16 countries in the Asia-Pacific region, has led to impressive sales growth for Cresemba® (Isavuconazol). The continued strong performance in these regions has triggered a second milestone payment of USD 2.5 million to Basilea. This partnership aims to address the rising global demand for innovative antifungal medications, with Cresemba being particularly well-received in China. The success underscores the drug's high clinical value for patients with life-threatening infections, highlighting the joint commitment of Basilea and Pfizer to make Cresemba accessible to affected patients worldwide.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001100864-de) on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,express","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}